Fungal Diseases News

Two widely available serum marker blood tests, galactomannan and 1,2-beta-D-glucan, may improve diagnostic sensitivity in cases of invasive fungal infections, according to a study.

I think it was in 1965 — so, a long time ago — that I finished my internship in the U.K. and wanted to do something a little bit more interesting than staying on the usual rotation through jobs.

For the latest story in our “Life during COVID” series, we asked experts to describe the impact the pandemic has had on patient health and the practice of medicine in the United States.

Only a handful of commonly used disinfectants — primarily chlorine-based disinfectants — were consistently effective against the four major clades of Candida auris, researchers reported.

An estimated 1 billion people worldwide develop a fungal infection each year. Of these, approximately 1.6 million will die because of their infection, a toll surpassing diseases such as malaria and tuberculosis.

Hospitalizations that involved fungal infections increased by more than 8% in the United States during the COVID-19 pandemic compared with previous years, researchers found.

HOUSTON — Data from a cloud-based surveillance system showed a substantial increase in cases of Candida auris in the United States during a recent 6-month period, researchers reported at ASM Microbe.

Health officials identified the first cases of severe tinea, or ringworm, caused by Trichophyton indotineae in the U.S., according to case reports published in MMWR.

SEATTLE — The first U.S. cluster of pediatric Candida auris cases was likely caused by shared mobile medical equipment that was not properly sanitized after being used for adult patients, an investigation found.

The FDA approved rezafungin for injection to treat candidemia and invasive candidiasis in adults, offering a new treatment for people with limited or no other options.